Breakthrough Insights from Duke-NUS-Led Stomach Cancer Research
A pioneering study from Duke-National University of Singapore Medical School (Duke-NUS) and the National University Health System (NUHS) has illuminated how multiple factors converge to dramatically elevate the risk of stomach cancer, also known as gastric cancer. Published in the prestigious journal Cancer Discovery on January 14, 2026, the research titled "Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence" analyzed over 1,500 samples of intestinal metaplasia (IM)—a precancerous condition—from patients across six countries, including Singapore, Japan, South Korea, Hong Kong, Taiwan, and the United States. This international effort, coordinated under the Singapore Gastric Cancer Consortium (SGCC), reveals that age-related changes, smoking, infiltration by oral bacteria, and specific genetic mutations interact in a complex web, potentially multiplying the risk up to sixfold.
The findings underscore the heterogeneity of IM, where only a subset progresses to full-blown gastric cancer. By pinpointing these synergistic risks, the study paves the way for precision screening and early interventions, particularly relevant in Singapore where gastric cancer claims 300 to 500 lives annually and ranks among the top 10 cancer-related killers.
Unpacking Intestinal Metaplasia: The Precancerous Gateway
Intestinal metaplasia (IM) occurs when the normal cells lining the stomach transform into cells resembling those of the intestine, a response often triggered by chronic inflammation such as from Helicobacter pylori (H. pylori) infection. While IM is a well-established precursor to gastric cancer, not all cases advance—a critical gap this Duke-NUS study addresses through single-cell genomic profiling.
Researchers identified 47 significantly mutated genes in IM tissues, marking the earliest detectable genetic shifts. This step-by-step process begins with chronic gastritis, progresses to IM, then dysplasia, and finally invasive cancer, unfolding over decades. In high-risk populations like those in East Asia, including Singaporeans of Chinese descent, IM prevalence is higher due to dietary, genetic, and environmental factors.
Understanding IM fully—its full name being complete or incomplete intestinal metaplasia based on histological subtypes—allows for targeted monitoring. For instance, incomplete IM carries a higher progression risk, emphasizing the need for endoscopic surveillance in at-risk individuals.
The Role of Ageing and Clonal Hematopoiesis in Cancer Susceptibility
Ageing emerges as a pivotal driver through clonal hematopoiesis (CH), where blood stem cells acquire somatic mutations and expand clonally. Common in older adults, CH weakens the immune system, impairing its ability to clear harmful invaders in the stomach lining.
The study found elevated CH prevalence in IM patients, particularly those over 50, correlating with higher gastric cancer incidence. This age-related phenomenon explains why stomach cancer typically manifests in individuals aged 50 to 70, with Singapore seeing peak diagnoses in this demographic. CH mutations, often in genes like DNMT3A or TET2, create a permissive environment for other risks to flourish.
Step-by-step, CH reduces immune surveillance: mutated blood cells produce dysfunctional neutrophils and macrophages, allowing persistent inflammation and metaplasia progression.
Smoking's Devastating Amplification of Oxidative Stress
Tobacco smoking exacerbates risk by inducing signature 17 (SBS17), a mutational pattern reflecting oxidative DNA damage. Absent in healthy gastric tissue, SBS17 was prevalent in IM samples, directly worsened by smoking exposure.
Smokers with IM showed heightened SBS17 signatures, linking to faster cellular transformation. In Singapore, where smoking rates hover around 13% among adults, this modifiable factor urges public health campaigns. Quitting smoking not only halts SBS17 accumulation but also mitigates CH expansion, offering a dual benefit.
- Short-term: Reduces inflammation within months.
- Long-term: Lowers cumulative DNA damage over years.
- Evidence: Smokers had 2-3 times higher IM progression markers.
Oral Bacteria Infiltration: An Unexpected Culprit
Beyond traditional H. pylori, the study spotlights oral bacteria like Streptococcus anginosus group infiltrating the stomach, especially in CH patients. Weakened immunity from ageing or smoking allows these microbes to colonize, fueling chronic inflammation.
In Singapore's multicultural context, where diets rich in preserved foods may alter oral microbiomes, this finding resonates. Bacteria trigger cytokine release, promoting metaplasia. Future strategies might include oral hygiene or targeted antimicrobials alongside H. pylori eradication, which affects 30-40% of Singaporeans.
Genetic Mutations at the Core: ARID1A and Beyond
Among the 47 driver genes, ARID1A—a tumor suppressor mutated in 17-27% of gastric cancers—stood out. Its loss disrupts chromatin remodeling, weakening cellular safeguards against metaplasia progression.
ARID1A-mutated IM cells showed poorer prognosis and higher cancer transition rates. Other mutations interact: CH genes compound with ARID1A, creating a high-risk genotype. Genetic testing for these could stratify patients, much like BRCA in breast cancer.
In Singapore's genetic diversity, with higher East Asian-specific variants, personalized genomics via institutions like A*STAR Genome Institute gains traction.
Photo by riddle_unsolved on Unsplash
Synergistic Interactions: Why Risks Multiply Dramatically
The study's power lies in dissecting synergies: CH (age) + smoking (SBS17) + bacteria + ARID1A loss create a perfect storm, amplifying risk sixfold. For example, CH patients with oral bacteria had accelerated IM-to-cancer shifts.
This multi-hit model mirrors Knudson's two-hit hypothesis but extends to microbial and lifestyle factors. In real-world cases, a 60-year-old Singaporean smoker with H. pylori history and CH might warrant intensive screening.
Gastric Cancer Burden in Singapore: A Local Perspective
Singapore reports about 1,000 new gastric cancer cases yearly, with age-standardized incidence around 15-20 per 100,000—higher than Western rates but declining due to H. pylori screening pilots. Mortality stands at 300-500 annually, disproportionately affecting males and older adults.
Cultural factors like salted fish consumption interplay with genetics. The SGCC's longitudinal cohort since 2007 provides invaluable data, highlighting Singapore's proactive stance.
National Cancer Centre Singapore StatisticsPrevention and Screening Strategies Informed by the Study
Leveraging findings, high-risk identification via CH testing, smoking cessation programs, and microbiome analysis could transform prevention. Singapore's Health Promotion Board advocates H. pylori tests for those over 50 with family history.
- Endoscopic surveillance for IM patients.
- Antibiotic regimens targeting oral bacteria.
- Lifestyle: Quit smoking, balanced diet low in processed meats.
Actionable: Discuss family history with GPs; consider breath tests for H. pylori.
Promising Therapies: Pyrvinium and Beyond
Repurposing pyrvinium—an FDA-approved anti-parasitic—shows promise in reversing IM by inhibiting Wnt signaling. Preclinical mouse and organoid studies confirmed reduced metaplasia.
SGCC plans early-phase trials within 1-2 years. This chemoprevention approach could halt progression pre-cancer, akin to statins for heart disease.
Duke-NUS and Singapore's Higher Education Research Leadership
Duke-NUS, a collaboration between Duke University and National University of Singapore (NUS), exemplifies Singapore's biomedical hub status. Co-senior authors Prof. Patrick Tan (Dean, Duke-NUS) and Prof. Yeoh Khay Guan (NUHS CEO) lead SGCC, involving NUS Yong Loo Lin School of Medicine and NTU's Lee Kong Chian School of Medicine.
This study highlights opportunities in cancer genomics research. Aspiring researchers can pursue research jobs or postdoc positions in Singapore's universities. For career guidance, visit how to write a winning academic CV.
Future Directions and Global Implications
Validating biomarkers across populations will refine risk models. Integrating AI for genomic prediction, as in other Duke-NUS works, promises personalized medicine. Globally, with 769,000 gastric cancer deaths in 2020, these insights could save millions.
In Singapore, policy shifts toward IM-focused screening loom. Researchers eye microbiome therapies and CH-modulating drugs.
Photo by GEE MENG WAH on Unsplash
Empowering Careers in Oncology Research
This study spotlights the impact of academic research in Singapore. Explore Singapore higher ed jobs, university jobs, and faculty positions in biomedical sciences. Rate professors via Rate My Professor, seek higher ed career advice, or browse higher-ed-jobs and research-jobs to join the fight against cancer.